Literature DB >> 9366788

Changes in aortic wall stiffness in men with alpha 1-antitrypsin deficiency.

A R Ahlgren1, E Piitulainen, B Sonesson, T Länne.   

Abstract

OBJECTIVES: To examine the diameter and distensibility of the abdominal aorta in patients with severe alpha 1-antitrypsin deficiency, and to compare the results with those of normal subjects.
MATERIAL AND METHODS: Abdominal aortic diameter and stiffness (beta) was measured using echo-tracking sonography in 19 men (mean age 50, range 25-79) and 17 women (mean age 46, range 26-62) with severe alpha 2-antitrypsin deficiency. The results were compared with those of healthy individuals of corresponding age and gender.
RESULTS: There was no significant difference in the abdominal aortic diameter between controls and patients with alpha 1-antitrypsin deficiency when corrected for age, sex and body surface area (men p = 0.20, women p = 0.10). Men with alpha 1-antitrypsin deficiency showed significantly lower stiffness in the abdominal aorta compared to controls (p = 0.025), whereas women did not (p = 0.17).
CONCLUSIONS: No significant difference in abdominal aortic diameter could be detected in patients with alpha 1-antitrypsin deficiency compared with controls. However, aortic distensibility in men with alpha 1-antitrypsin deficiency is altered. This may reflect early vessel wall abnormality.

Entities:  

Mesh:

Year:  1997        PMID: 9366788     DOI: 10.1016/s1078-5884(97)80236-5

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  7 in total

1.  Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency.

Authors:  James M Duckers; Dennis J Shale; Robert A Stockley; Nichola S Gale; Bronwen A J Evans; John R Cockcroft; Charlotte E Bolton
Journal:  Respir Res       Date:  2010-12-07

2.  Cardiovascular risk in patients with alpha-1-antitrypsin deficiency.

Authors:  Sebastian Fähndrich; Frank Biertz; Annika Karch; Björn Kleibrink; Armin Koch; Helmut Teschler; Tobias Welte; Hans-Ulrich Kauczor; Sabina Janciauskiene; Rudolf A Jörres; Timm Greulich; Claus F Vogelmeier; Robert Bals
Journal:  Respir Res       Date:  2017-09-15

3.  Severe α1-antitrypsin deficiency associated with lower blood pressure and reduced risk of ischemic heart disease: a cohort study of 91,540 individuals and a meta-analysis.

Authors:  Sine Voss Winther; Dunia Ahmed; Suzan Al-Shuweli; Eskild Morten Landt; Børge Grønne Nordestgaard; Niels Seersholm; Morten Dahl
Journal:  Respir Res       Date:  2022-03-09

4.  Relationship Between α1-Antitrypsin Deficiency and Ascending Aortic Distention.

Authors:  Farouk Dako; Huaqing Zhao; Alexandra Mulvenna; Yogesh Sean Gupta; Scott Simpson; Friedrich Kueppers
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-04-30

5.  New circulating biomarkers for predicting cardiovascular death in healthy population.

Authors:  Olle Melander; Javier Modrego; Jose J Zamorano-León; Juana M Santos-Sancho; Vicente Lahera; Antonio J López-Farré
Journal:  J Cell Mol Med       Date:  2015-08-10       Impact factor: 5.310

6.  Inflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.

Authors:  I Mark Olfert; Moh H Malek; Tomas M L Eagan; Harrieth Wagner; Peter D Wagner
Journal:  BMC Pulm Med       Date:  2014-06-30       Impact factor: 3.317

7.  Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US.

Authors:  Robert Sandhaus; Charlie Strange; Glenda Stone; M Chris Runken; Christopher M Blanchette; Reuben Howden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.